Gregory D. Plowman;Wei-Ching Liang;Yan Wu;Weilan Ye
发明人:
Wei-Ching Liang,Gregory D. Plowman,Yan Wu,Weilan Ye
申请号：
US13112839
公开号：
US08840887B2
申请日:
2011.05.20
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to the use of VEGF antagonists and a novel anti-α5β1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permeability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5β1 antibodies and methods of making and using them.
